Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203694 · ClinicalTrials.gov registry record · NA
Effects of Walking and Heating on Vascular Function in Diabetic Patients
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT03203694: Completed NA study, sponsored by University of Missouri-Columbia.
NCT03203694 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03203694, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).
Primary Outcome
Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed at baseline (t0) and after 60 minutes of insulin stimulation (t60).
Interventions
- BEHAVIORAL Walking: Intervention arm in diabetics
- OTHER Walking: No intervention in diabetics
- OTHER Walking: Healthy cohort as reference controls
- BEHAVIORAL Lower body heating: Intervention arm in healthy subjects
- BEHAVIORAL Lower body heating: Intervention arm in diabetics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2022-03-10 |
| Phase | NA |
What the finished NCT03203694 record still lists
NCT03203694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Walking: Intervention arm in diabetics is the first listed.
NCT03203694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03203694 about?
NCT03203694 is a clinical study titled "Effects of Walking and Heating on Vascular Function in Diabetic Patients". The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).
What is the current status of trial NCT03203694?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2017-12-04. Estimated completion is 2022-03-10.
What interventions are being tested in trial NCT03203694?
The interventions under investigation include: Walking: Intervention arm in diabetics (BEHAVIORAL), Walking: No intervention in diabetics (OTHER), Walking: Healthy cohort as reference controls (OTHER), Lower body heating: Intervention arm in healthy subjects (BEHAVIORAL), Lower body heating: Intervention arm in diabetics (BEHAVIORAL).
Who is sponsoring clinical trial NCT03203694?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03203694's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI